Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/265556
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Pharmacokinetics, biodistribution, and biosafety of pegylated gold nanoparticles in vivo |
Autor: | Kozics, Katarina; Sramkova, Monika; Kopecka, Kristina; Begerova, Patricia; Manova, Alena; Krivošíková, Zora; Sevcikova, Zuzana; Líšková, Aurélia; Rollerova, Eva; Dubaj, Tibor; Puntes, Víctor F. CSIC ORCID; Wsolova, Ladislava; Simon, Peter; Tulinská, Jana; Gabelova, Alena | Palabras clave: | Gold nanoparticles Rats Pharmacokinetics Biodistribution Histopathology Clinical chemistry Hematology |
Fecha de publicación: | 28-jun-2021 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Nanomaterials 11(7): 1702 (2021) | Resumen: | Despite the obvious advantages of gold nanoparticles for biomedical applications, controversial and incomplete toxicological data hamper their widespread use. Here, we present the results from an in vivo toxicity study using gold nanoparticles coated with polyethylene glycol (PEG-AuNPs). The pharmacokinetics and biodistribution of PEG-AuNPs were examined in the rat’s liver, lung, spleen, and kidney after a single i.v. injection (0.7 mg/kg) at different time intervals. PEG-AuNPs had a relatively long blood circulation time and accumulated primarily in the liver and spleen, where they remained for up to 28 days after administration. Increased cytoplasmic vacuolation in hepatocytes 24 h and 7 days after PEG-AuNPs exposure and apoptotic-like cells in white splenic pulp 24 h after administration has been detected, however, 28 days post-exposure were no longer observed. In contrast, at this time point, we identified significant changes in lipid metabolism, altered levels of liver injury markers, and elevated monocyte count, but without marked biological relevance. In blood cells, no DNA damage was present in any of the studied time intervals, with the exception of DNA breakage transiently detected in primary kidney cells 4 h post-injection. Our results indicate that the tissue accumulation of PEG-AuNPs might result in late toxic effects. | Versión del editor: | http://doi.org/10.3390/nano11071702 | URI: | http://hdl.handle.net/10261/265556 | DOI: | 10.3390/nano11071702 | Identificadores: | doi: 10.3390/nano11071702 issn: 2079-4991 |
Aparece en las colecciones: | (CIN2) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Pharmacokinetics_PEGylated_gold_nanoparticles.pdf | 4,12 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
25
checked on 13-may-2024
Download(s)
31
checked on 13-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons